Stocktitan

Published October 5, 2026

Psyence Biomedical: AdvisorShares reports 6.78% stake | PBM SEC Filing - Stock Titan

Read the full story at Stocktitan

Ibogaine Licence for Texas Ibogaine Research Corporation; Sep 23, 2026 Psyence BioMed Announces Strategic Ibogaine Investment · All PBM news. Trending.